Could a weekly shot stop diabetes after pregnancy diabetes?

NCT ID NCT05569772

Recruiting now Prevention Sponsor: Universitaire Ziekenhuizen KU Leuven Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times

Summary

This study tests whether the drug semaglutide can prevent type 2 diabetes in women who had gestational diabetes and now have high blood sugar after pregnancy. About 252 women will receive either semaglutide or a placebo for several months. The goal is to see if the drug lowers the risk of developing diabetes within five years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLUCOSE INTOLERANCE AFTER A RECENT HISTORY OF GESTATIONAL DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes glucose intolerance prediabetes syndrome type 2 diabetes mellitus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLUCOSE INTOLERANCE AFTER A RECENT HISTORY OF GESTATIONAL DIABETES

Contacts and locations

Locations

AZ Groeninge Kortrijk
RECRUITING

Kortrijk, Belgium
AZ St Jan Brugge
RECRUITING

Bruges, Belgium
AZ Turnhout
RECRUITING

Turnhout, Belgium
AZORG
RECRUITING

Aalst, Belgium
CHU de Liège
RECRUITING

Liège, Belgium
Centre Hospitalier Mouscron
RECRUITING

Mouscron, Belgium
Erasme
RECRUITING

Brussels, Belgium
Jan Yperman
RECRUITING

Ieper, Belgium
UZ Brussel
RECRUITING

Brussels, Belgium
UZ Leuven
RECRUITING

Leuven, Belgium
UZA
RECRUITING

Antwerp, Belgium
Vitaz
RECRUITING

Sint-Niklaas, Belgium
ZAS
RECRUITING

Antwerp, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.